Elizabeth A Grammer has sold ARDX and made no open-market buys since Sep 2016
Insider at Ardelyx, Inc.
SEC CIK 0001213041 · Filings on SEC.gov ↗
Every filing
18 filings since Sep 2016, newest first
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
Insider
Ardelyx, Inc.
EVP and General Counsel
Ardelyx, Inc.
EVP and General Counsel
Ardelyx, Inc.
SVP and General Counsel
Ardelyx, Inc.
SVP and General Counsel
About Elizabeth A Grammer
Grammer Elizabeth A is a corporate insider at Ardelyx, Inc. (NASDAQ: ARDX), where she is identified in regulatory filings as an officer-level insider and has been reported with the title "See Remarks" in certain Form 4 filings related to insider transactions.( Earlier filings and company disclosures indicate that Elizabeth A. Grammer has served in senior legal and administrative leadership roles at Ardelyx, including Vice President and General Counsel and later Chief Legal and Administrative Officer, reflecting her responsibility for the company’s legal affairs and corporate administration.( As an individual insider, she has been a long‑tenured member of Ardelyx’s executive team and is listed among the company’s named insiders alongside other key executives.(
Grammer is an individual, not a company or investment firm, and has been an active participant in Ardelyx’s Rule 10b5‑1 trading plans and ongoing insider trading activity disclosures.( Her transactions, including multiple reported sales of Ardelyx common stock under pre‑arranged trading plans, underscore her status as a significant equity holder and senior officer, with hundreds of thousands of shares sold over time and a remaining direct ownership position disclosed in recent filings.( While public sources focus primarily on her insider trading and executive roles at Ardelyx rather than her broader career history or education, her progression from General Counsel to Chief Legal and Administrative Officer indicates a career anchored in corporate law and governance for a clinical‑stage biopharmaceutical company.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.